Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H JACKSON

Showing results (711-720 of 770) with videos related to

Pageof 77
Sort By:
The American Journal of Clinical Nutrition|May 16, 2022
Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trialKevin C Klatt, Melissa Q McDougall, Olga V Malysheva, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
Iscience|August 9, 2021
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2Jun-Gyu Park, Fatai S Oladunni, Mohammed A Rohaim, et al.
Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Blood|August 20, 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic ProfilingSina Alexandra Beer, David A Cairns, Charlotte Pawlyn, et al.
Science Immunology|February 23, 2023
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
Pageof 77

Showing results (711-720 of 770) with videos related to

Sort By:
Pageof 77
The American Journal of Clinical Nutrition|May 16, 2022
Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trialKevin C Klatt, Melissa Q McDougall, Olga V Malysheva, et al.
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
The Lancet. Oncology|July 21, 2011
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trialGareth J Morgan, J Anthony Child, Walter M Gregory, et al.
Iscience|August 9, 2021
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2Jun-Gyu Park, Fatai S Oladunni, Mohammed A Rohaim, et al.
Journal of Medical Genetics|October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphomaL J Worrillow, A G Smith, K Scott, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Blood|August 20, 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic ProfilingSina Alexandra Beer, David A Cairns, Charlotte Pawlyn, et al.
Science Immunology|February 23, 2023
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
Pageof 77